Bullish option flow detected in Novartis with 5,000 calls trading, 3x expected, and implied vol increasing over 1 point to 18.29%. Jul-23 105 calls and Jul-23 100 calls are the most active options, with total volume in those strikes near 4,300 contracts. The Put/Call Ratio is 0.05. Earnings are expected on July 18th.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NVS:
- BLCO Expands Dry Eye Disease Portfolio with Acquisition of Xiidra from Novartis
- Carisma announces first patient dosed in Phase I clinical trial of CT-0508
- Coherus Biosciences to acquire Surface Oncology in stock for stock transaction
- Lexicon has ‘only un-partnered asset’ in SGLT2i space, says Piper
- Chinook downgraded to Market Perform from Outperform at William Blair